Role of tumour markers in monitoring epithelial ovarian cancer

被引：1
|
作者：
Meyer, T [1 ]
Rustin, GJS [1 ]
机构：
[1] Mt Vernon Hosp, Dept Med Oncol, Northwood HA6 2RN, Middx, England
来源：
BRITISH JOURNAL OF CANCER | 2000年 / 82卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Currently the only tumour marker to have a well-defined and validated role in the management of ovarian cancer is CA125. Changes in the level of CA125 can be used as a reliable indication of response or progression according to various criteria, but it does not yet have a clear place in diagnosis or prognosis. Its value as part of a screening tool and during routine follow-up remain the subject of ongoing trials. Other markers remain experimental and do not have a well-defined contribution to make at present. (C) 2000 Cancer Research Campaign.
引用
收藏
页码：1535 / 1538
页数：4
相关论文
共 50 条
  • [21] Role of lymphangiogenesis in epithelial ovarian cancer
    Sundar, S. S.
    Zhang, H.
    Brown, P.
    Manek, S.
    Han, C.
    Kaur, K.
    Charnock, M. F. L.
    Jackson, D.
    Ganesan, T. S.
    BRITISH JOURNAL OF CANCER, 2006, 94 (11) : 1650 - 1657
  • [22] The role of anthracyclines in epithelial ovarian cancer
    Vermorken, JB
    Harper, PG
    Buyse, M
    ANNALS OF ONCOLOGY, 1999, 10 : 43 - 50
  • [23] Role of lymphangiogenesis in epithelial ovarian cancer
    S S Sundar
    H Zhang
    P Brown
    S Manek
    C Han
    K Kaur
    M F L Charnock
    D Jackson
    T S Ganesan
    British Journal of Cancer, 2006, 94 : 1650 - 1657
  • [24] The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression
    Junli Deng
    Li Wang
    Hongmin Chen
    Lei Li
    Yiming Ma
    Jie Ni
    Yong Li
    Cancer and Metastasis Reviews, 2013, 32 : 535 - 551
  • [25] The role of tumour-associated MUC1 in epithelial ovarian cancer metastasis and progression
    Deng, Junli
    Wang, Li
    Chen, Hongmin
    Li, Lei
    Ma, Yiming
    Ni, Jie
    Li, Yong
    CANCER AND METASTASIS REVIEWS, 2013, 32 (3-4) : 535 - 551
  • [26] SEROLOGICAL MONITORING OF EPITHELIAL OVARIAN-CANCER
    FISKEN, J
    LEONARD, RCF
    BADLEY, A
    JONRUP, I
    ASPINALL, L
    STURGEON, C
    ROULSTON, JE
    DISEASE MARKERS, 1991, 9 (3-4) : 175 - 190
  • [27] Possible role of ovarian epithelial inflammation in ovarian cancer
    Ness, RB
    Cottreau, C
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (17): : 1459 - 1467
  • [28] Response: Comment on searching for prognostic markers for stage I epithelial ovarian cancer: A role for systemic inflammatory markers
    Borella, Fulvio
    Bertero, Luca
    Valabrega, Giorgio
    Fucina, Stefano
    Cassoni, Paola
    Benedetto, Chiara
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2024, 166 (01) : 459 - 460
  • [29] Circulating Inflammation Markers and Risk of Epithelial Ovarian Cancer
    Clendenen, Tess V.
    Lundin, Eva
    Zeleniuch-Jacquotte, Anne
    Koenig, Karen L.
    Berrino, Franco
    Lukanova, Annekatrin
    Lokshin, Anna E.
    Idahl, Annika
    Ohlson, Nina
    Hallmans, Goran
    Krogh, Vittorio
    Sieri, Sabina
    Muti, Paola
    Marrangoni, Adele
    Nolen, Brian M.
    Liu, Mengling
    Shore, Roy E.
    Arslan, Alan A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (05) : 799 - 810
  • [30] The role of tumour markers and biomarkers in colorectal cancer
    Lech, G.
    Slotwinski, R.
    Krasnodebski, I. W.
    NEOPLASMA, 2014, 61 (01) : 1 - 8
12345